Anthony Rodriguez

Anthony brings over a decade of experience in commercializing medical devices, primarily in the vascular access market. After receiving his PhD in Bioenigineering from the University of Washington, Anthony worked as a product specialist at Gore navigating the VIABAHN™ Stent Graft through the final stages of the REVISE study, FDA clearance and initial market launch of the new dialysis access indication. He also worked at St. Jude Medical (now Abbott) to develop the launch strategy for MultiPoint Pacing for their Cardiac Resynchronization Therapy devices. He transitioned back to vascular access with TVA Medical to help gain FDA clearance and develop the market for the endovascular fistula (endoAVF) creation. He stayed on at Becton Dickinson for a year after TVA’s acquisition to help launch endoAVF into the U.S. market and train both the internal team as well as physicians on the device and new procedure. He joined Laminate to continue his work on improving vascular access for dialysis patients by bringing VasQ as well as other innovations in the company’s pipeline to market.